Facilitating Access to Approved Medication
Get Access To Capmatinib Tablets
Capmatinib Tablets
Active Ingredient(s): Capmatinib Tablets
Trade Name: On Request
Packaging: Tablets
Strength: Tablets: 150 mg and 200 mg
Indications: For the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDAapproved test.
What is Capmatinib Tablets used for?
On August 10, 2022, the FDA granted regular approval to capmatinib for adult patients with metastatic non-small cell lung cancer whose tumors have a mutation leading to mesenchymal-epithelial transition exon 14 skipping, as detected by an FDA-approved test. Capmatinib is a kinase inhibitor indicated for the treatment of adults with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDA-approved test.
Note: (For Prescribing Information Approved Drugs, see)
- The Food and Drug Administration (FDA), USA.
- The European Medicines Agency (EMA).
Disclaimer
All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Alpelisib Tablets is a pharmaceutical drug To access this medicine, a prescription of your treating doctor is necessary.. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.
Lucknow Speciality Pharma, Lucknow, India
Lucnow Speciality Pharma is registered in Lucknow, India. Registration Number : AAKFL2122J1ZB Under GST Act
Branch Offices in India : Lucknow | Agra | Jaipur | Varanasi | New Delhi
2nd Floor, 203-A, Felix Square, Golf City, Gomti Nagar, Lucknow, Uttar Pradesh 226030
Mobile :+91 97600 14849 / 9555306364
WhatsApp :+91 97600 14849 / 9555306364